Senator Casey: “Because of [the IRA], seniors and families are spending less on their prescription drugs, Americans are spending less on their electricity bills, and we’re on the cusp of a manufacturing renaissance in the United States”
WESA: ““This is real life for real people,” Casey said of the program’s impact. “It’s a big breakthrough.”
PENNSYLVANIA — As a result of the Senator Casey-backed Inflation Reduction Act, Medicare now has the power to negotiate drug prices for the first time. Last week, the first round of prescription drugs to be negotiated were announced, a process which will lower prescription drug costs for the 63 million Americans on Medicare.
Pennsylvanians across the commonwealth have been reading and hearing about how Senator Casey has delivered lower prescription drug prices and continues to fight for working families.
Read the coverage below:
Lehigh Valley Business: Lauded by Dems, lambasted by Republicans, IRA marks one-year anniversary
- U.S. Senator Bob Casey (D-PA) marked the anniversary by stating that the IRA is lowering the cost of healthcare and prescription drugs for American families and seniors, including a $35 cap on insulin for seniors. Casey said the act likewise lowers energy costs from electricity bills to electric vehicles and invests in American manufacturing projects using American materials and investments in energy communities.
- “Because of this law, seniors and families are spending less on their prescription drugs, Americans are spending less on their electricity bills, and we’re on the cusp of a manufacturing renaissance in the United States,” Casey said in a statement. “By investing in America’s clean energy capabilities, we’re on track to meet our climate goals. Pennsylvania families and communities are feeling the impacts of the Inflation Reduction Act, but I’m proud to say that the best of this law is yet to come.”
WESA: Casey touts policy wins on pregnant-worker protections, drug prices during Pittsburgh stop
- U.S. Sen. Bob Casey took a kind of victory lap Tuesday in Pittsburgh, visiting the headquarters of Goodwill Southwestern Pennsylvania to celebrate a couple of long-delayed Democratic policy wins.
- Casey’s visit also coincided with a major step for another long-cherished Democratic priority: allowing Medicare to negotiate with drugmakers on the price of medications.
Times Leader: Eliquis, Jardiance among 10 drugs picked for Medicare price negotiations
- U.S. Sen. Bob Casey, D-Scranton, Chairman of the U.S. Senate Committee on Aging, applauded the Biden Administration’s announcement of the first 10 prescription drugs selected for Medicare price negotiation
- “In the Inflation Reduction Act, Democrats fought hard to finally allow Medicare to negotiate drug prices,” Casey said. “Because of this law, pharmaceutical companies will no longer be able to charge Medicare recipients unfair prices for the medications they need, and millions of Americans will see lower drug costs as a result. This is a huge step to lower drug costs for Americans, but it’s also just the beginning. More drugs will be added to the list in the years to come, and Democrats are going to keep fighting to lower everyday costs for Americans and ensure that families don’t have to choose between their health and their bank account.”
PCNC Pittsburgh: Sen. Casey on Medicare Negotiations
- Reporter: Medicare can now negotiate with drug companies and the cost of those drugs as part of the Inflation Reduction Act. The drugs […….] are used to treat conditions like blood clots, blood cancer, diabetes, arthritis and heart failure. Senator Bob Casey says the program isn’t intended to end there.
- Senator Casey: It’s a big breakthrough, but we want that list of 10 to grow to 20 and 30 and 100 and more, so that we have so many drugs that will be the subject of that negotiation to keep prices low.
WPXI Pittsburgh: Sen. Casey on Medicare Negotiations
- The new provision, part of the Inflation Reduction Act, allows the government to negotiate lower prices on 10 drugs, including the ones there on your screen [Eliquis, Jardiance, Entresto, Enbrel]. Pennsylvania Senator Bob Casey says the program is not intended to end there.